By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cosmo Pharmaceuticals S.p.A. 

Via C. Colombo 1

Lainate    I – 20020  Italy
Phone: 39-02-9333-7614 Fax: 39-02-9333-7663



Company News
Cosmo Pharm Eyes $107 Million+ in Dermatology Unit IPO 6/15/2015 6:10:20 AM
Cosmo Pharmaceuticals S.p.A. Plans To Move Its Management To Ireland 10/15/2014 6:29:10 AM
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014 5:51:58 AM
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal 9/17/2014 6:33:51 AM
AIMM Therapeutics in Strategic Partnership With Cosmo Pharmaceuticals S.p.A. to Combine Cosmo's Extended Release Technology & AIMM's High Quality Antibodies to Successfully Combat Gastrointestinal Disease 12/19/2012 9:41:54 AM
Cosmo Pharmaceuticals S.p.A. CEO Sees $1.5 Billion Dye Luring Buyer by 2013 9/25/2012 7:55:14 AM
Cosmo Pharmaceuticals S.p.A. Announces Positive Top-Line Results in EU Phase III Clinical Study Evaluating Budesonide MMX In Ulcerative Colitis 11/8/2010 1:00:15 PM
Cosmo Pharmaceuticals S.p.A. Reports Exciting Results in P.O.C. Alopecia Study 10/6/2010 12:43:29 PM
Santarus Inc. (SNTS) and Cosmo Pharmaceuticals S.p.A.'s Anti-Inflammatory Drug Budesonide MMX Meets Late-Stage Goal 9/30/2010 6:54:19 AM
Cosmo Pharmaceuticals S.p.A. Reports Increased Revenues And Operating Profit In First-Half 2010 7/30/2010 12:52:48 PM